How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
Health news round-up: Vaccines, male contraception and medicines mix-ups Senior clinical reporter Joanna Robertson summarises some important developments in health news you may have missed.…
Health news round-up: mosquitoes, new HIV guidelines and research into cannabis and psilocybin Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Beyond GLP-1: the next wave of weight-loss medication innovation From agonists and antagonists to ultrasound therapy, an in-depth look at the drug development pipeline has highlighted several promising new potential weight-loss medicines.…
Health news round-up: diabetes and weight-loss news from EASD Senior clinical reporter Joanna Robertson summarises clinical trial results from the European Association for the Study of Diabetes conference in Vienna.…
Daily GLP-1 receptor agonist pill leads to ‘significant’ weight loss Average body weight loss in participants taking 36mg of orforglipron (Emgality; Eli Lilly) was 11.2%.…
Weight-loss medicines should be delivered through pharmacies, says Community Pharmacy Scotland Offering weight-loss medicines in community pharmacies would “ensure safety and effectiveness”, according to Community Pharmacy Scotland's manifesto for the 2026 Scottish Parliamentary elections.…
Health news round up: long-term conditions, cancer drugs and a medicines pricing stand-off Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Reimbursement for NHS Mounjaro dispensing confirmed for September 2025 Community Pharmacy England has reached an agreement with the Department of Health and Social Care to ensure that pharmacy owners are not dispensing at a loss.…
Diabetes medicines spend rises by almost 20% in one year NHS Business Services Authority data have also revealed that almost 1 million patients received diabetes medicines in the most deprived areas of England in 2024/2025.…
